BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14757134)

  • 1. Protein kinase C-beta inhibition and diabetic microangiopathy: effects on endothelial permeability responses in vitro.
    Idris I; Gray S; Donnelly R
    Eur J Pharmacol; 2004 Feb; 485(1-3):141-4. PubMed ID: 14757134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of high glucose and phorbol-myristate-acetate-induced endothelial cell permeability by protein kinase C inhibitors LY379196 and hypocrellin A.
    Dang L; Seale JP; Qu X
    Biochem Pharmacol; 2004 Mar; 67(5):855-64. PubMed ID: 15104238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High glucose-induced human umbilical vein endothelial cell hyperpermeability is dependent on protein kinase C activation and independent of the Ca2+-nitric oxide signalling pathway.
    Dang L; Seale JP; Qu X
    Clin Exp Pharmacol Physiol; 2005 Sep; 32(9):771-6. PubMed ID: 16173935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation.
    Quagliaro L; Piconi L; Assaloni R; Martinelli L; Motz E; Ceriello A
    Diabetes; 2003 Nov; 52(11):2795-804. PubMed ID: 14578299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C phosphorylates caldesmon77 and vimentin and enhances albumin permeability across cultured bovine pulmonary artery endothelial cell monolayers.
    Stasek JE; Patterson CE; Garcia JG
    J Cell Physiol; 1992 Oct; 153(1):62-75. PubMed ID: 1522136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C beta inhibition: A novel therapeutic strategy for diabetic microangiopathy.
    Idris I; Donnelly R
    Diab Vasc Dis Res; 2006 Dec; 3(3):172-8. PubMed ID: 17160912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protective effect of protein kinase C inhibitor Ro-31-8425 on hyperpermeability of human umbilical vein endothelial cells exposed to high glucose in vitro].
    Zou M; Xue Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1787-91. PubMed ID: 23268411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha.
    Venugopal SK; Devaraj S; Yang T; Jialal I
    Diabetes; 2002 Oct; 51(10):3049-54. PubMed ID: 12351446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of protein kinase C activation and the vascular complications of diabetes.
    Das Evcimen N; King GL
    Pharmacol Res; 2007 Jun; 55(6):498-510. PubMed ID: 17574431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of PKC-beta in PTH, TNF-alpha, and IL-1 beta effects on IL-6 promoter in osteoblastic cells and on PTH-stimulated bone resorption.
    Radeff JM; Nagy Z; Stern PH
    Exp Cell Res; 2001 Aug; 268(2):179-88. PubMed ID: 11478844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bradykinin- and thrombin-induced increases in endothelial permeability occur independently of phospholipase C but require protein kinase C activation.
    Aschner JL; Lum H; Fletcher PW; Malik AB
    J Cell Physiol; 1997 Dec; 173(3):387-96. PubMed ID: 9369952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II promotes glucose-induced activation of cardiac protein kinase C isozymes and phosphorylation of troponin I.
    Malhotra A; Kang BP; Cheung S; Opawumi D; Meggs LG
    Diabetes; 2001 Aug; 50(8):1918-26. PubMed ID: 11473056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glucose-induced macrophage foam cell formation.
    Li L; Sawamura T; Renier G
    Circ Res; 2004 Apr; 94(7):892-901. PubMed ID: 15001526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C betaII activation induces angiotensin converting enzyme expression in neonatal rat cardiomyocytes.
    Zhang Y; Bloem LJ; Yu L; Estridge TB; Iversen PW; McDonald CE; Schrementi JP; Wang X; Vlahos CJ; Wang J
    Cardiovasc Res; 2003 Jan; 57(1):139-46. PubMed ID: 12504823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can protein kinase C beta-selective inhibitor, ruboxistaurin, stop vascular complications in diabetic patients?
    He Z; King GL
    Diabetes Care; 2005 Nov; 28(11):2803-5. PubMed ID: 16249561
    [No Abstract]   [Full Text] [Related]  

  • 16. Activation of protein kinase C isoforms and its impact on diabetic complications.
    Geraldes P; King GL
    Circ Res; 2010 Apr; 106(8):1319-31. PubMed ID: 20431074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation.
    Park JY; Takahara N; Gabriele A; Chou E; Naruse K; Suzuma K; Yamauchi T; Ha SW; Meier M; Rhodes CJ; King GL
    Diabetes; 2000 Jul; 49(7):1239-48. PubMed ID: 10909984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased endothelial albumin permeability mediated by protein kinase C activation.
    Lynch JJ; Ferro TJ; Blumenstock FA; Brockenauer AM; Malik AB
    J Clin Invest; 1990 Jun; 85(6):1991-8. PubMed ID: 2347922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of vascular endothelial growth factor on cultured endothelial cell monolayer transport properties.
    Chang YS; Munn LL; Hillsley MV; Dull RO; Yuan J; Lakshminarayanan S; Gardner TW; Jain RK; Tarbell JM
    Microvasc Res; 2000 Mar; 59(2):265-77. PubMed ID: 10684732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of protein kinase C isoforms in rat epididymal microvascular endothelial barrier function.
    Harrington EO; Brunelle JL; Shannon CJ; Kim ES; Mennella K; Rounds S
    Am J Respir Cell Mol Biol; 2003 May; 28(5):626-36. PubMed ID: 12707019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.